GlassScriptPhysician profile
Andrew Michael Mills
NPI 1487034153
$1,251.89
in general payments reported to CMS, 2019-2025
16 companies · $238 in 2025
The $238 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $309 · 2021: $110 · 2023: $221 · 2024: $73.31 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $528.99 | 2019-2020 | |
| Kerecis Limited | $119.13 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ethicon US, LLC | $110.48 | 2021 | |
| Abbvie INC. | $90.19 | 2025 | |
| Davol INC. | $89.98 | 2025 | Arista |
| Allergan, INC. | $80.78 | 2019 | |
| Smith+Nephew, INC. | $47.72 | 2023 | Pico, Grafix Pl |
| Integra Lifesciences Corporation | $37.84 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kls-Martin L.P. | $23.07 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $19.77 | 2024 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $18.98 | 2025 | Dupixent |
| Amgen INC. | $18.68 | 2025 | Tavneos |
| Harmony Biosciences LLC | $17.79 | 2024 | |
| Pharmacosmos Therapeutics INC. | $17.79 | 2024 | Monoferric |
| Janssen Biotech, INC. | $16.88 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $13.82 | 2023 | Advantagerib |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.